153 results on '"Colantuono, Stefania"'
Search Results
2. B Cell in Health and Disease
3. The New Paradigm: The Role of Proteins and Triggers in the Evolution of Allergic Asthma
4. The last step to achieve barrier damage control
5. Severe asthma: One disease and multiple definitions
6. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
7. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
8. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)
9. CD21low B cells in systemic sclerosis: A possible marker of vascular complications
10. A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders
11. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia.
12. Immunoglobulin Free Light Chains in Severe Asthma Patient: could they be a new biomarker?
13. Clinical research coordinators: Key components of an efficient clinical trial unit
14. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia
15. Delayed hypersensitivity to dimethyl fumarate: report of one case and literature review
16. Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis
17. Clinical research coordinators: Key components of an efficient clinical trial unit
18. Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis
19. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity
20. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.
21. Heterogeneous Condition of Asthmatic Children Patients: A Narrative Review
22. Autoimmune hepatitis with eosinophilic infiltration responsive to anti-interleukin-5 receptor treatment: a case report and literature review.
23. Severe asthma: One disease and multiple definitions
24. Metabolomics, Microbiota, and In Vivo and In Vitro Biomarkers in Type 2 Severe Asthma: A Perspective Review
25. The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti–hepatitis C virus therapy
26. β-Lactam Allergy and Cross-Reactivity: A Clinician’s Guide to Selecting an Alternative Antibiotic
27. CD21low B cells are predictive markers of new digital ulcers in systemic sclerosis
28. Cryoglobulins: putative effectors of adaptive immune response
29. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy
30. Mutational and immunogenetic landscape of HCV ‐associated B‐cell lymphoproliferative disorders
31. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression
32. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
33. Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review
34. Clinico‐immunological outcomes of HCV‐cured cryoglobulinemia: Lower relapse rate with interferon‐based than interferon‐free therapy
35. Basophil activation and serum IL‐5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti‐IL‐5 drugs
36. Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis
37. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)
38. Biomarkers of minimal residual disease in rituximab‐treated patients with mixed cryoglobulinemia
39. Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study
40. Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports.
41. Immunobiology of essential mixed cryoglobulinemia
42. CD21low B cells are predictive markers of new digital ulcers in systemic sclerosis.
43. Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia.
44. Long‐lasting persistence of large B‐cell clones in hepatitis C virus‐cured patients with complete response of mixed cryoglobulinaemia vasculitis
45. Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia
46. Clinico‐immunological outcomes of HCV‐cured cryoglobulinemia: Lower relapse rate with interferon‐based than interferon‐free therapy.
47. A case of tension-type headache in fibromyalgia
48. Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer
49. MODULATION OF GUT MICROBIOTA IN PATIENTS WITH NICKEL ALLERGY AND IBS AFTER DIET AND PROBIOTICS SUPPLEMENTATION
50. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.